Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCodeDrugDate from ▲Subject
 2.7.2025G.L. Pharma GmbH (GLH-2)9501CAgomelatine G.L. Pharma (tbl flm 30x25 mg (blis.OPA/Al/PVC/Al))31.8.2025Z
 17.6.2025Viatris Limited (VIM)7087ABrufedol Rapid 400 mg (tbl flm 24x400 mg (blis.PVC/PE/PVDC/Al))31.8.2025Z
 9.6.2025Viatris Healthcare Limited (VIM-1)89022Kombi-Kalz 500 mg/800 IU žuvacie tablety (tbl mnd 30x500 mg/800 IU (obal HDPE))31.8.2025Z
 18.6.2025TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)8596DPaliperidón Teva 75 mg injekčná suspenzia s predĺženým uvoľňovaním (sus ijp 1x75 mg (striek.inj.napln.+2x ihla))18.8.2025R
 9.6.2025Zentiva, k.s. (ZNT-1)6188DSunitinib Zentiva 25 mg (cps dur 30x25 mg (fľ.HDPE))15.8.2025Z
 28.6.2025Teva B.V. (TEV-NL-4)91376Gabapentin-Teva 300 mg (cps dur 200(2x100)x300 mg (blis.PVC/PVDC/Al))15.8.2025R
 4.6.2025Zentiva k.s. (ZNT-3)6283DEverio Airmaster 50 mikrogramov/500 mikrogramov (plv ido 1x60 dávok (blis.Al/OPA/PVC+ inhalátor))8.8.2025Z
 9.4.2025Teva B.V. (TEV-NL-4)5043DSTOPTUSSIN tablety (tbl 1x30 (blis.Al/PVC))4.8.2025R
 26.6.2025Otsuka Pharmaceutical Netherlands B.V. (OTS-NL)6077EAbilify Maintena 960 mg injekčná suspenzia s predĺženým uvoľňovaním v naplnenej injekčnej striekačke (sus iph 1x960 mg (striek.inj.napl + 2 bezp.ihly))1.8.2025U
 16.5.2025BAUSCH HEALTH IRELAND LIMITED (BAU-3)42080SUPRELIP (cps dur 30x200 mg (blis. PVC/Al))1.8.2025Z
 16.5.2025Bausch Health Ireland Limited (BAU-1)51897Relistor 12 mg/0,6 ml injekčný roztok (sol inj 7x0,6 ml/12 mg (7 liek.inj.skl.+7 steril.inj.striek.+14 alkoh.tamp.))1.8.2025Z
 21.5.2025Teva B.V. (TEV-NL-4)0486EAtorvastatín/Ezetimib Teva 40 mg/10 mg (tbl flm 90x40 mg/10 mg (blis.OPA/Al/PVC/Al))1.8.2025R
 4.6.2025TEVA GmbH (TEV-DE)7218DRivaroxabán Teva 2,5 mg filmom obalené tablety (tbl flm 56x1x2,5 mg (blis.PVC/PVDC/Al-jednotliv.dáv.))1.8.2025R
 17.4.2025B.Braun Melsungen AG (BME)3644DIbuprofen B. Braun 200 mg (sol inf 10x50 ml (fľ.LDPE))1.8.2025Z
 22.11.2024Sanofi B.V. (SAV-NL)85530Evoltra 1 mg/ml infúzny koncentrát (con inf 1x20 ml/20 mg (liek.inj.skl.))31.7.2025Z

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)